Millions of people around the world live with aching knees or painful hips caused by osteoarthritis. The condition often develops slowly over many years and can make everyday activities such as walking, climbing stairs, or even standing up very difficult.
In severe cases, people may eventually need major surgery to replace a damaged joint. Now, a new study suggests that a small daily pill called colchicine may help reduce the chances of needing these surgeries.
Osteoarthritis is the most common form of arthritis. It mainly affects joints that carry body weight, especially the knees and hips. Inside a healthy joint, the ends of the bones are covered by a smooth material called cartilage.
This cartilage works like a cushion. It allows the bones to move smoothly against each other when a person walks or bends a joint. Over time, however, the cartilage can slowly break down. When this happens, bones may rub against each other, causing pain, swelling, and stiffness.
As people age, the risk of osteoarthritis increases. Years of movement and pressure on the joints gradually wear down the cartilage. Other factors can also increase the risk. For example,
previous injuries, heavy physical work, sports damage, and extra body weight can all put additional stress on joints. Scientists have also learned that low levels of inflammation inside the joint may speed up the damage.
Because inflammation appears to play a role in osteoarthritis, researchers have been searching for ways to reduce it. One drug that caught their attention is colchicine. This medicine has been used for decades to treat gout, a painful disease caused by the buildup of crystals in joints.
Colchicine works by calming inflammation in the body. Doctors have also used it to treat other inflammatory conditions because it can prevent certain immune reactions that damage tissues.
A group of scientists wondered whether this same drug might also help slow the damage seen in osteoarthritis. If inflammation contributes to joint damage, then reducing that inflammation might protect the joint and delay the need for surgery.
To explore this idea, researchers in the Netherlands carried out a large clinical study involving more than 5,500 people. The participants were between 35 and 82 years old and were treated at 43 medical centers located in Australia and the Netherlands. The study followed these participants for about 29 months, which is a little over two years.
The participants were divided into two groups. One group took a low daily dose of colchicine, which was 0.5 milligrams per day. The other group received a placebo. A placebo is a pill that looks the same as the real medicine but does not contain an active drug. Using a placebo allows scientists to fairly compare the effects of a treatment.
During the study period, the researchers closely monitored how many participants needed knee or hip replacement surgery. These surgeries are usually recommended when joint damage becomes severe and pain cannot be controlled by other treatments.
At the end of the study, the scientists noticed a clear difference between the two groups. Among the people taking colchicine, only about 2.5 percent eventually needed knee or hip replacement surgery. In comparison, about 3.5 percent of those taking the placebo required surgery.
Although the difference may seem small, it is important because it suggests the drug could slow the worsening of osteoarthritis in some people. Even delaying surgery for a few years can greatly improve a person’s quality of life and reduce healthcare costs.
The researchers also noticed that the benefit appeared stronger in men than in women. However, the study was not specifically designed to study gender differences. Because of this, scientists say more research is needed to understand whether women would receive the same level of benefit.
One reason colchicine is especially interesting to doctors is that it has already been used safely for many years. Since it is a well-known medicine, doctors understand its side effects and safe dosage levels. This could make it easier to study and possibly introduce as a treatment for osteoarthritis if future research confirms the benefits.
However, scientists caution that people should not start taking colchicine on their own without medical advice. Like all medications, it can cause side effects and must be used under a doctor’s supervision. More studies are also needed to fully understand how well it works for osteoarthritis and which patients may benefit the most.
In the meantime, doctors still recommend several basic strategies to help manage osteoarthritis. Staying physically active, maintaining a healthy body weight, and strengthening the muscles around joints can all help reduce stress on the knees and hips. Physical therapy and pain management treatments can also help many people remain active for longer.
The new findings highlight how important inflammation may be in the development of osteoarthritis. If medications like colchicine can control this inflammation, they might help slow the disease and delay the need for major joint surgery.
The research was published in the medical journal Annals of Internal Medicine. If future studies confirm the results, colchicine could become a simple and affordable way to help people with osteoarthritis protect their joints and stay mobile for longer.
If you care about arthritis, please read studies about extra virgin olive oil for arthritis, and pomegranate: A natural treatment for rheumatoid arthritis.
For more information about arthritis, please see recent studies about how to live pain-free with arthritis, and results showing medical cannabis may help reduce arthritis pain, back pain.
Copyright © 2026 Knowridge Science Report. All rights reserved.
